NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of LifeMD, Inc. (NASDAQ: LFMD) between May 7, 2025 and August 5, 2025, both dates inclusive (the “Class Period”). The lawsuit seeks to recover damages for LifeMD, Inc. investors under the federal securities laws. To join the LifeMD class action, go to https://rosenlegal.com/submit-form/?case_id=43404 or call Phillip Kim, Esq. toll-
Related Questions
Are there any immediate regulatory or disclosure requirements for LFMD that could trigger further volatility or affect investor sentiment?
How likely is the lawsuit to result in a settlement or judgment that could materially affect LFMD's market capitalization?
What is the historical impact of similar securities class actions on the stock price and trading volume of small-cap biotech companies?